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Heart failure (HF) is one of the most common causes of morbidity and mortality worldwide. 
Although many patients suffering from HF die from sudden cardiac death caused by arrhythmias, 
the mechanism linking HF remodeling to an increased arrhythmogenic propensity remains 
incomplete. Independently of the etiology of the disease, HF is typically characterized by a 
progressive loss of transverse tubule (T-tubule) domains, which leads to an altered distribution of L-
type Calcium channels (LTCCs).  Ischemic cardiomyopathy (ICM) is usually accompanied by an 
increase in LTCC open probability (Po) in the T-tubules which depends on the activity of protein 
kinase A (PKA). In dilated cardiomyopathy (DCM) on the other hand, the increased LTCC Po on 
the non-T-tubule sarcolemma results from enhanced calcium-calmodulin kinase II (CaMKII) 
modulation. Microdomain degradation also causes the disruption of the β2 adrenergic receptor 
(β2AR) and phosphodiesterase (PDE) signaling localizations, normally confined to the dyadic space.  
The goal of this study was to analyze how these subcellular changes affect the function of 
LTCCs and lead to the emergence of ventricular cell-level triggers of arrhythmias. Furthermore, we 
aimed to compare how the two different pathways lead to different phenotypes in ICM vs. DCM.  
Using computational modeling, we analyzed the behavior of the LTCC current (ICaL) under 
basal and sympathetic stimulation and its effect on cellular action potentials (APs). Our results 
showed that channels redistributed from the T-tubular membrane to the bulk of the sarcolemma 
displayed an altered function in their new, non-native signaling domain. The changes in LTCC 




triggered reentrant arrhythmias only in the DCM model. 
Thus, our work shows that altered LTCC function is a potential cause for the emergence of 
cell-level triggers of arrhythmia, and that CaMKII, β2ARs and PDEs present useful therapeutic 
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Chapter 1: Background and motivation 
 
1.1 The Electrophysiology of the Heart 
The heart is a vital organ that acts as a pump, moving blood through arteries and veins to 
deliver oxygen and nutrients to the rest of the body and remove carbon dioxide (Figure 1.1). The 
heart consists mostly of cardiac muscle (myocardium), a special type of muscle composed of fiber-
like arrays of electrically coupled excitable cells (cardiomyocytes). Electrical signals in the heart 
function as triggers, protectors and controllers of contractions. Under normal conditions, pacemaker 
cells located in the sinoatrial (SA) node initiate a contraction by spontaneously generating an 
electrical signal. This electrical signal propagates from cell to cell in a wave-like manner, causing the 
upper chambers of the heart (the left and right atrium) to contract and pump blood into the relaxed 
lower chambers of the heart (the ventricles).  From an electrical point of view, the atria are almost 
completely separated from the ventricles by the fibrous body of the heart. Thus, the electrical signal 
which originated in the atria can only reach the ventricles via the atrioventricular (AV) node and the 
bundle of His. The main role of the AV node is to provide a delay in electrical conduction and slow 
the electrical wave, allowing the ventricles to properly fill with blood before their contraction. After 
passing through the AV node, the electrical signal moves through the bundle of His and reaches the 
Purkinje fibers, a specialized network of cells which rapidly carry the electrical signal to the apex of 
the heart. Once the electrical excitation is transferred to the ventricular myocardium through the 




contract and pump blood to the body and lungs. The whole heart then returns to diastole, until the 











Figure 1.1 Cardiac anatomy and electrical conduction system.   
 
1.1.1 Cardiac Action Potentials 
In the heart, an electrical signal is called action potential and is defined as a rapid 
depolarization followed by a slower repolarization of the excitable membrane of a cardiomyocyte. 
This membrane, also known as the sarcolemma of the cell acts as a capacitor and is characterized by 
a difference in voltage across its two faces known as the transmembrane potential (Vm).  
The driving force behind the change in transmembrane potential that takes place during an 
AP is the flow of ions down their concentration gradient, across the membrane through specialized, 




neighboring cells through intercellular channels called gap junctions, thus allowing APs to propagate 
from one cell to the next.  
There are two types of APs observed in the heart: slow responses characteristic of the nodal 
cells, and fast responses observed in the atrial and ventricular myocytes, as shown in Figure 1.2. The 
fast responses consist of five distinct phases. The initial one, also known as the resting phase or 
phase 4 is characterized by a transmembrane voltage of about -80 mV caused by the inward rectifier 
K+ current (IK1) flowing through the only open channels. Phase 0 starts as an external stimulus 
brings Vm above the threshold potential of near -40 mV, which in turn causes the IK1 channels to 
close and the Na+ channels to open (Figure 1.2), allowing Na+ ions to flow inside the cell and drive 
the membrane potential up towards the Nernst potential of Na+. The Na+ ion channels inactivate 
rapidly, signaling the beginning of phase 1 in which transient outward K+ channels activate, allowing 
K+ ions to flow outward and the membrane to briefly repolarize (the notch in the AP morphology). 
Next, the transient K+ channels close, and the LTCCs and delayed rectifier K+ channels open, 
allowing the inward Ca2+ current to balance the outward K+ current and bringing about the plateau 
phase (phase 2) of the AP in which the change in the transmembrane potential is minimal. Because 
LTCC channels deactivate before the delayed rectifier K+ channels, the delayed rectifier K+ current 
(IK) brings Vm down during phase 3. As IK channels close and IK1 channels open once again, the cell 
returns to the resting phase.  
Although similar, the AP in ventricular cells has a faster upstroke, and longer plateau phase 
than that in atrial cells, displaying more of a spike-and-dome shape as opposed to a triangular one as 




The span of time between phase 0 and phase 3 is called the action potential duration (APD), 
it can be measured for different levels of repolarization (50% and 90% in Figure 1.2), and is highly 


















Figure 1.2 Cardiac AP and underlying currents.1  
                                                          
1 Modified from Nerbonne JM. Voltage-regulated potassium channels. In: Zipes D, Jalife J, eds. Cardiac 




1.1.2 Excitation-contraction Coupling 
Every AP experienced by a cardiomyocyte causes it to shorten in a process known as 
excitation-contraction coupling. The duration of the action potential in the heart coincides with the 
duration of the contraction. The main link between the two processes is represented by the increase 
in the concentration of Ca2+ ions inside the cytoplasm during an AP which could not take place 
without the existence of T-tubules. T-tubules are specialized regions of the sarcolemma which 
penetrate deep inside the cytosol and carry the electrical signal towards the center of the myocyte 
(figure 1.3). The sarcoplasmic reticulum (SR) is located in close proximity to these structures and 
acts as a Ca2+ storage unit. A specific molecule called calsequestrin binds to the calcium (Ca2+) ions 
inside the SR and it allows it to accumulate at very high concentrations. The narrow region between 
T-tubules and the SR is called the dyadic space. When a stimulus causes the membrane to depolarize 
during an AP, the voltage-gated LTCCs activate and allow Ca2+ ions to flow from the extracellular 
space, down the concentration gradient, into the dyadic space. There, Ca2+ binds to specialized 
molecules called Ryanodine receptors (RyRs), causing them to open and release a significant amount 
of Ca2+ into the dyadic space – a process called Ca2+ - induced Ca2+ release (CICR). The high 
concentration of Ca2+ ions inside the dyadic space causes the Ca2+-sensitive LTCCs to close. Ca2+ 
then spreads into the bulk of the cytoplasm. There, Ca2+ binds to Troponin C which inhibits 
Troponin I and leads to a conformational change in Tropomyosin. As this takes place, the binding 
sites between the actin and myosin filaments become exposed and myosin heads bind do the actin 
filaments causing cross-bridge cycling and allowing the two filaments to slide against each-other, 




is pumped back into the SR by the SERCA pump. At the same time, the Na+/Ca2+ exchanger 












Figure 1.3 Excitation-contraction coupling 
 
1.1.3 Modulation of Cardiac Excitation 
Each heart beat originates from the pacemaker cells located in the SA node. Without any 
external influence, the heart would contract about 100 times each minute. However, the heart rate 
and cardiac output need to fluctuate in order to meet the body’s cells requirements for oxygen and 
nutrients under varying conditions. Thus, heart rate and contractility (the ability of the cardiac 
muscle to produce force during a contraction) are regulated by both the sympathetic and the 




human heart is under constant influence of the parasympathetic system via the vagus nerve which 
causes our resting heart rate to stay around 60-70 beats/min. Sympathetic modulation has the 
opposite effect, speeding up the heart rate by affecting the slope of Phase 4 of the pacemaker cells in 
the SA node. In the heart, the main receptors for the catecholamines released by the neurons from 
the sympathetic nervous systems are the β1 and β2 adrenergic receptors (β1ARs and β2ARs in 
Figure 1.4). The β1ARs outnumber the β2ARs in cardiomyocytes in a ratio of 4:1. Stimulation of 
these receptors results in a positive chronotropic effect (increase in heart rate), a positive ionotropic 
effect (increase in contractility) and a positive dromotropic effect (increase in conductivity). 
Sympathetic neurotransmitters called catecholamines released by neurons bind to βARs, inducing a 
conformational change and causing coupling with heterotrimeric G-proteins. G-proteins then 
dissociate into active Gα and Gβ subunits. Gα subunits proceed to bind to adenylyl cyclase (AC), 
activating it, and leading to an increase in the production of the second messenger cyclic adenosine 
monophosphate (cAMP). This messenger molecule is responsible for the activation of numerous 
other pathways, enzymes, ion channels and transcription factors. For the purpose of this study, the 
most important enzyme activated by cAMP is the cAMP-dependent protein kinase A which is 





















Figure 1.4 Modulation of Cardiac Excitation 
 
1.2 Heart Failure 
HF does not have a generally accepted definition. It is described as a syndrome, which 
develops as a result of an underlying cardiac disease and is recognized clinically based on the many 
symptoms (e. g. breathlessness, ankle swelling, and fatigue) and signs (e.g.  elevated jugular venous 
pressure, pulmonary crackles, and displaced apex beat) produced by intricate circulatory and 
neurohormonal responses to altered cardiac function [1], [2]. It is broadly characterized as the 
pathophysiologic state in which a dysfunction of the cardiac muscle is responsible for the heart 
failing to pump blood at a rate proportionate to the metabolizing tissues’ requirements. HF is one of 




concern due to the high cost of long-term drug treatment as well as frequent hospitalizations. This 
economic impact on health services is projected to increase, as the occurrence of HF, currently 
affecting about 5.7 million Americans is expected to rise by 46% from  2012 to 2030 as the 
population ages [3]. HF patients are 6 to 9 times more likely to die from sudden cardiac death due to 
lethal arrhythmias than healthy individuals [4]. Despite these troubling statistics, the mechanism 
linking pathophysiological remodeling to arrhythmogenesis in HF patients remains poorly 
understood. This has resulted in ineffective pharmacological therapy for preventing sudden 
arrhythmic death and in unsuccessful approaches to arrhythmia risk stratification of HF patients [5], 
[6].  
 
1.2.1 Heart Failure Remodeling 
A group of both structural and functional pathological remodeling changes are constantly 
observed in HF patients [7]. These alterations are detected at various levels of structural organization 
(molecular, cellular and whole-organ levels), and give rise to ventricular dysfunction and the 
emergence of malignant arrhythmias. The clinical diagnosis of cardiac remodeling is usually based on 
detection of structural changes at organ level such as changes in the diameter of the ventricles, mass 
(hypertrophy or atrophy), the presence of areas of scar after myocardial infarction, fibrosis or 
inflammatory infiltrates [7]. However, experimental studies have shown that these changes are 
complemented at cellular and molecular levels by even more remodeling, specifically in the structural 
and electrophysiological properties of cardiomyocytes, which can trigger the occurrence of 
ventricular arrhythmias. Looking at transmembrane currents in HF myocytes, we can make a few 




during the depolarization phase of an AP is decreased in HF, while the density of the late sodium 
current (INaL) active during the plateau and repolarization phases is increased. The LTCC current 
density remains the same, while all potassium currents (Ito, IK1, IKr and IKs) show a decrease. Lastly, 
the activity of the SERCA and NaK pumps in HF is downregulated, while that of the NCX is 
upregulated [8]. All these changes, combined with a disruption of the T-tubular microdomain have 
been sowed to give rise to triggers of arrhythmia such as early and delayed afterdepolarizations 
(EADs and DADs).    
 
1.3 Objectives  
The goal of this work was to explore a novel set of mechanisms by which HF remodeling, 
specifically at subcellular domain leads to an increased risked of lethal arrhythmias in human HF. 
The specific aims of this work were: 
• Specific Aim 1: Identify the cellular mechanisms by which degradation of subcellular 
microdomains in HF myocytes impact the function of LTCC and lead to the generation of cellular-
level triggers of arrhythmia.  
• Specific Aim 2: Evaluate the difference between the nanoscale regulation of L-type 









Chapter 2: General Methods 
 
2.4 Cardiac Computational Modeling 
The electrophysiological functions of the heart described above can be simulated with high 
accuracy using mathematical modeling. Features from molecular, cell, and tissue levels can be 
integrated using computer simulations in order to study their contributions to both normal cardiac 
function as well as organ-scale arrhythmogenic phenomena. Product of decades of research, 
modern-day models of atria and ventricles allow scientists to study cardiac electrophysiology at a 
high spatiotemporal resolution, and propose solutions to current clinical problems.  The building 
blocks of such models and the methods used in cardiac computational modeling are described in the 
sections below.  
 
2.5 Hodgkin and Huxley vs. Markov Formalism 
The first mathematical model able to reproduce transmembrane currents and APs was 
formulated by Hodgkin and Huxley in 1952, based on their observations of the squid giant axon’s 
electrophysiology. In their model, an ion channel can be either open or closed, depending on the 
states of the channel’s gates. As the behavior of each gate is assumed to be independent from that of 
the other gates of the channel, the current through such a channel is a time- and voltage-dependent 
function directly proportional to the open probabilities of the channels’ gates. The ionic current thus 




Im =  Cm
dVm
dt
+  Iionic + Istim 
Im represents the total membrane current density, Cm is the membrane capacitance per unit 
area, Vm represents the transmembrane potential, Iionic is the total ionic current density, and Istim 
represents the current density of a transmembrane stimulus. Many modern computational AP 
models (Grandi et al., 2010; Luo and Rudy, 1994; O’Hara et al., 2011; ten Tusscher et al., 2004) use 
the Hodgkin and Huxley formalism to describe membrane kinetics. By subdividing Iionic into multiple 
components such as INa, INaL, ICaL, IK1, Ito, IKr, IKs, INaCa, and INaK based on detailed experimental 
measurements using voltage clamping, and numerically integrating these equations, scientists have 
been able to successfully reproduce APs from various cell types within the hearts of different 
species.  An equivalent formalism to that of Hodgkin and Huxley, but based on Markov chains can 
be used to substitute the equations for one or all ionic currents. In this paradigm, Markov chains are 
used to represent the time- and voltage- dependent state transitions for each individual ion channel. 
The ionic current can, in this case, be expressed as a function of the occupation of the open state. 
Markov formalism is usually used to represent the behavior of ionic currents when genetic 
mutations are present, but can also successfully model wild-type ionic currents.  Although for the 
purpose of this study we can represent our ionic currents using either formalism, computing the 
ionic currents using the Markov method usually requires a larger number of state variables and more 
computational power. This has a small effect in single-cell simulations, but can lead to a considerable 
increase in computational time in whole-organ 3D simulations. Therefore, while we will use Markov 
formalism to calibrate our models in the second part of this work, in our whole organ simulations 







Chapter 3:  Degradation of T-Tubular Microdomains 
and Altered cAMP Compartmentation Lead to 
Emergence of Arrhythmogenic Triggers in Heart 
Failure Myocytes: An In-Silico Study 
 
This study has been published in Frontiers in Physiology [9]. 
 
3.1 Introduction 
HF causes the heart to undergo remodeling across multiple scales [10].  However, studies 
have shown that nearly all arrhythmias in non-ischemic heart failure and approximately 50% of 
those in ischemic heart failure develop due to abnormal automaticity or triggered activity such as 
EADs and DADs [11]. 
Previous research has also shown that remodeling at cellular and subcellular levels 
characteristic of HF can lead to AP prolongation and delayed repolarization, which could be 
important causes of EAD formation. In turn, these changes could be linked to the modification in 
ion channel behavior, especially the LTCC whose activity is highly regulated via cAMP by various 




observed in unhealthy myocytes [10], [12], [13]. These subcellular changes are often exacerbated by 
sympathetic stimulation which increases the levels of cAMP and can cause an increase in inward 
current, particularly through LTCCs. This, in turn, can destabilize the labile plateau phase of APs [4]. 
However, the exact mechanism linking changes in T-tubule organization and in cAMP 
compartmentation to abnormal LTCC function and the development of arrhythmogenic triggers 
remains unknown. 
LTCCs play an important role in excitation-contraction coupling and influence the electrical 
and mechanical functioning of cardiac muscle [14]. In ventricular myocytes, under normal 
conditions, LTCCs are clustered in the transverse tubules (T-tubules). Gradual T-tubule loss, a 
known effect of HF, forces LTCCs to be redistributed to the surface membrane where they 
maintain their function but experience a different environment than that of the dyadic space [15]. 
Within the T-tubules, LTCCs are usually associated with a number of specific 
macromolecular signaling complexes and scaffolding proteins which allow for precise control of 
Ca2+ signaling [16], [17]. One such signaling complex is the β2AR, responsible for mediating the 
functional effects of cathecolamines in the heart, and more specifically, inside T-tubules, where they 
are confined. Selective sympathetic stimulation of the two receptor subtypes, β1AR and β2AR, lead 
to distinct physiological responses, based on their different localization and kinetics [18]. β1ARs 
stimulate the cAMP-dependent PKA-mediated phosphorylation of phospholamban and cardiac 
contractile proteins. Sympathetic stimulation of the β2AR, on the other hand, activates the G-
protein/adenylyl cyclase (AC)/cAMP/PKA pathway which leads to the phosphorylation of several 




membrane to the non-T-tubular membrane areas where stimulation of the receptor induces far 
reaching cAMP signals, similar to those elicited by β1AR stimulation [19], [18].  
Apart from the molecules mentioned above, PDEs, which cleave cAMP into adenosine 
monophosphate (AMP) and protein phosphatases that dephosphorylate LTCCs also have an effect 
on the phosphorylation state of LTCCs. Furthermore, PDE molecules also show a high localization 
to the T-tubule membrane in healthy cells and along with AC and PKA play a key role in controlling 
the compartmentation of cAMP (Heijman, Volders, Westra, & Rudy, 2011). Activation of PKA by 
cAMP leads to PDE phosphorylation, increasing its activity, which in turn removes phosphorylation 
from other molecules. Thus, PDEs provide a negative feedback-loop for cAMP level control.  
Disrupting the localized PDE expression could lead to increased levels of cellular cAMP and 
inhibition of the PDE hydrolyzing effect [19]. 
The goal of this study was to uncover the mechanism by which HF-induced changes in 
cAMP compartmentation combines with the LTCCs T-tubule-to-surface-membrane redistribution 
to cause an abnormal LTCC current which promotes the development of EADs in human 
ventricular myocytes. To this end, we developed a novel model, using the O’Hara-Rudy human 
cardiac ventricular AP formulation [21] combined with the Heijman et al. β-adrenergic signaling 
simulations [22] as our cornerstone. As the specific aim of this study was to dissect the effects of 
β2AR signaling localization loss and PDE-dependent cAMP level control impairment on the 
electrophysiological function of the cell, our single-cell model brought together various aspects of 
microdomain remodeling characteristic to HF, such as LTCC redistribution presented by Sanchez 




and colleagues [18]. Our results show valuable insight into the pathophysiological changes that favor 
the development of cellular arrhythmogenic triggers in HF patients. 
 
3.2 Methods 
3.2.1 Overview of the Modeling Approach to Simulate the Behavior of 
Human HF Ventricular Myocyte 
As a baseline model representing the healthy human ventricular myocyte, we used the 
O’Hara-Rudy human ventricular AP model [21] combined with the Heijman et al. β-adrenergic 
signaling model [22], as described previously [8]. Within this model, the behavior of the LTCCs is 
described using a Hodgkin-Huxley formulation, and LTCC CDI depends on the concentration of 
Ca2+ the channels sense. To simulate a human HF ventricular myocyte, we incorporated various 
changes into the baseline model, reproducing ionic and structural remodeling observed in vitro, and 
described in detail in the sections below.  
First, similar to a previous study [15], we introduced T-tubular microdomain loss, resulting in 
LTCCs and Na+/Ca2+ exchangers (NCXs)  being redistributed from the T-tubular membrane to the 
bulk of the sarcolemma and in RyRs decoupling from LTCCs. However, instead of creating a single 
model of an HF ventricular myocyte as in the study by Sanchez and colleagues, we permitted the 
amount of microdomain loss to vary and thus created a family of HF myocyte models that allowed 
us to analyze different stages of the disease. The progression of the disease was also modeled by 
letting the phosphorylation level of the channels to vary based on the presence of β2ARs and PDEs 




stage of the disease was, the more PDE molecules were redistributed from the dyadic space to the 
bulk of the cytoplasm, and the more β2ARs were shifted from the T-tubular to the surface 
membrane. Since LTCCs would display a different behavior based on their location and the 
signaling domain they experience, we divided LTCCs within a myocyte into 6 different subgroups 
(Subgroups A – F) based on their position in the T-tubular or surface membrane and their signaling 
environment, where they may or may not experience the phosphorylating effect of PKA and the 
hydrolyzing effect of PDEs (Figures 3.1A – 3.1F). The resulting models containing all LTCC 
populations were utilized to carry out computer simulations uncovering the mechanisms responsible 
for the generation of EADs in human HF myocytes under adrenergic stimulation. 
 
3.2.2 Introducing T-tubular Microdomain Degradation in HF 
The combined O’Hara-Rudy  and Heijman model contained LTCCs exclusively in the T-
tubular membrane[23]. We used a similar approach to that in the study by Sanchez and colleagues  
[15], and allowed for LTCCs to be redistributed to the surface membrane. Thus, in addition to the 
already defined dyadic volume, we included a sub-sarcolemmal volume which allowed for Ca2+ 
accumulation near the intracellular mouth of LTCCs in the surface membrane. We described fluxes 
from and into this volume in the O’Hara-Rudy myocyte model [21] based on the work of Grandi 
and colleagues [24] and Shannon and colleagues [25]. Similar to Sanchez et. al., we modeled the 
relocation of LTCCs to the surface membrane by allowing the redistributed channels to contribute 
to and sense the Ca2+ concentration from the sub-sarcolemmal volume as opposed to the dyadic 
volume for those remaining in the T-tubular membrane. However, to study the progression of the 




account for this HF-induced T-tubular degradation, we introduced the parameter f_TT in the model 
and used it to encode T-tubule integrity. The value of this parameter was allowed to range from fully 
intact (f_TT=1.0, 0% t-tubule loss) to completely degraded (f_TT=0.0, 100% T-tubule loss) in 
increments of 0.1. We then set the fraction of LTCCs that were redistributed from the T-tubule to 
the surface membrane to be directly proportional to the loss of T-tubules. Thus, when the T-tubular 
membrane was intact (f_TT=1.0), all LTCCs were confined to it. In contrast, when the 
microdomain was completely disrupted (f_TT=0.0), all LTCCs were redistributed to the surface 
membrane.  
 
3.2.3 Modeling the Effect of T-tubular Loss on the Na+/Ca2+ 
Exchanger and RyRs 
Two other molecules affected by the loss of T-tubular domains are the NCX molecules and 
RyRs. In the original O’Hara-Rudy model, RyRs are always associated with LTCCs from the T-
tubular membrane and only a fifth of the NCX are located in the surface membrane, while the rest 
reside in the T-tubular subspace [21]. The choice of including 20% of NCX molecules in the bulk of 
the sarcolemma is consistent with previous models [26], [27] and was validated based on its effect on 
the rate dependence of peak [Ca2+]i in [28]. We used the same approach as in the study by Sanchez 
and colleagues, and redistributed a fraction of NCXs proportional to the amount of de-tubulation 
from the T-tubular sites to the sarcolemma based on observations made by Gadeberg and 






3.2.4 Representing the Effect of β2ARs and PDEs Presence on 
LTCCs 
Activation of the β2AR leads to an increase in adenylyl cyclase (AC) activity which, in turn, 
increases the levels of cAMP. Next, cAMP binds to the regulatory subunits of PKA, enabling the 
catalytic subunits to phosphorylate their substrates at specific serine or threonine residues. This 
signaling cascade is counterbalanced by the hydrolyzing activity of PDEs. Specifically PDE3, and to 
a lesser extent PDE4 predominantly determine cAMP levels in the cytosol as well as in the dyadic 
space, by degrading cAMP [22].  While there are more isoforms of PDE [30] and models developed 
for each of them, we chose to focus exclusively on PDE3, as drugs that restore PDE3 activity in 
ischemic and dilated cardiomyopathies have been shown to have a cardio-protective effect. Because 
there is only one detectable phosphorylation site that allows PKA to regulate LTCCs [31], an LTCC 
can be characterized by one of two conditions: phosphorylated or not phosphorylated. In other 
words, an LTCC cannot be partially phosphorylated, and phosphorylation can be modeled as a 
binary process. Based on these observations, we divided all LTCCs within a myocyte into two 
different populations, phosphorylated and not phosphorylated.  Thus, in order to simplify our 
model, we only used the electrophysiological module of the Heijman et al. β-adrenergic signaling 
model [22], we fixed the phosphorylation levels for the base model, so that it matched experimental 
measurements, and modeled PDE activity loss to be directly proportional to the T-tubular 
microdomain loss.  
Therefore, we also introduced two new parameters, f_PDE and f_Β2AR to quantify the 
fractions of LTCCs that experience phosphorylation due to the activation of the β2AR /G-




words, localized upregulation of ICaL due to β2AR stimulation was encoded to affect only a certain 
proportion of LTCCs, which varied from all LTCCs (f_Β2AR = 1.0) to none (f_Β2AR =0.0) in 
increments of 0.1. Similarly, the hydrolyzing activity of PDEs was allowed to range from affecting 
no LTCC (f_PDE = 0.0), to affecting all LTCCs (f_PDE = 1.0) in steps of 0.1.  
 
 
3.2.5 Allowing LTCCs to Function in Different Locations and 
Signaling Domains 
A comprehensive population-based approach in which LTCCs were distributed between the 
6 different subgroups mentioned in the overview and described below was then used to integrate the 
effects of T-tubule loss and the disruption of β2AR and PDE signaling localization on the LTCC 
current in HF myocytes. The Hodgkin-Huxley formulation of LTCC current combines together the 
number of LTCCs and their conductance in order to obtain a current density for the whole cell. 
Empirically, no significant changes in LTCC current density have been observed in failing human 
cardiac myocytes [32], [33], which may be due to heart failure myocytes showing a decrease in LTCC 
number, paired with an increase of the channel’s activity [34]. However, in our myocyte model the 
total number of LTCCs and their conductance were kept constant, each LTCC being assigned a 
current (ICaL) equal to unity. This assumption was made in order to limit the degrees of freedom of 
our model, to be able to draw mechanistic insights from the data obtained. If an LTCC was 
phosphorylated by PKA, the amplitude of the current through that channel was increased by a 
factor of 2.5 [22]. Subgroup A, depicted in Figure 3.1, Subgroup A, contains channels identical to 




cAMP levels regulated by both PKA and PDE.  In the second group – subgroup B (Figure 3.1, 
Subgroup B), LTCCs located in the T-tubular membrane do not experience the hydrolyzing activity 
of PDE, so they are assumed to always be phosphorylated.  In contrast, the subgroup C of LTCCs 
(Figure 3.1, Subgroup C), which experience the activity of PDE, are assumed to never be 
phosphorylated as they lack association with β2ARs. Based on this logic, another subgroup could be 
defined as the channels lacking both PDE and β2AR in the T-tubular membrane, but physiologically, 
these would be indistinguishable from the channels in Subgroups C as they would never be 
phosphorylated. Therefore, we assumed they are also part of Subgroup C. The other three groups 
(Subgroups D - F) are similar to the ones just mentioned but are located in the surface cellular 
membrane as opposed to the T-tubular membrane. The total LTCC current for a cell was calculated 


















Figure 3.1 Schematic representation of LTCC subgroups A-F. LTCCs are located either in the 
T-tubular membrane (Subgroups A, B, C) or in the bulk of the sarcolemma (Subgroups D, E, F).  
LTCCs were either associated with both β2ARs and PDEs (Subgroups A, D), solely with β2ARs 
(Subgroups B, E), or not associated with β2ARs at all (Subgroups C, F). The channels were either 
phosphorylated (red) or unphosphorylated (green).   
 
3.2.6 The Effects of Phosphorylation on Other Molecules 
A similar population-based approach was used to represent the degree of PKA 
phosphorylation, in the presence or absence of β2AR stimulation, of seven different targets: RyR, 
Phospholamban (PLB), Slow Delayed Rectifier K+ Current (IKs), Fast Na
+ Current, Na+/K+ATP-ase 
Current (INaK), rapidly activating K
+ current (IKur) and Troponin I (TnI), as described by Heijman 
and colleagues [22]. 
Assuming that channel gating has no effect on phosphorylation, the molecules mentioned 
above can have only two distinct conformations (phosphorylated and non-phosphorylated). 
Therefore, each of the seven phosphorylation targets were divided into two subgroups: 
phosphorylated and not phosphorylated.  The effect of phosphorylation on each target, as described 
by Heijman and colleagues [22], was included in the model. Basal conditions were modeled to 
account for the phosphorylation of 25% of targets while β2AR stimulation led to the 
phosphorylation of 75% of each substrate population. These values were chosen in order to obtain 
LTCC current traces in the healthy myocytes similar to those experimentally recorded and presented 
by Bryant and colleagues [34]. In order to be as physiologically accurate as possible, the model also 




published data [15]. For each of these molecules it was assumed that PKA and CaMKII 
phosphorylation are independent processes. Therefore, the targets were divided into four 
populations. At each time step, the currents through the LTCCs and INa channels were computed for 
both (phosphorylated and non-phosphorylated) populations. The total current was obtained by 
adding together the currents through each population and thus integrating the β2AR and CaMKII 
cascades. While the level of PKA phosphorylation varied for the purpose of this study, the CaMKII 
phosphorylation level was kept constant. 
3.2.7 ICaL and Action Potential Duration (APD) Analysis Protocol 
APD90 was computed as the time point of 90% repolarization of the membrane potential 
minus the time point of maximal upstroke velocity (dV/dt)max. For the first part of the study, we 
established 6 different cases (case 1- 6) in which 80% of LTCCs within a cell were assigned to one of 
each of the six subgroups described above and in Figure 3.1, and for each case the remaining 
channels were distributed between the other 5 subgroups (Figure 3.2). This allowed us to observe 
and analyze separately the effects of LTCC redistribution, loss of β2AR signaling localization, and 
PDE’s impaired control of cAMP on the LTCC current and APD90. The model myocyte was first 
allowed to reach steady state under a voltage clamp of -96.7 mV. To determine the effect of each 
parameter (f_TT, f_Β2AR and f_PDE) on the LTCC current, the membrane voltage was then 
stepped up from -96.7 mV to  -6.7 mV, clamped again, and the LTCC current was recorded.  In 
order to analyze the effect of the same parameters on APD90, the myocyte was paced at near resting 





3.2.8 Protocol for Evaluating EADs in the Human Ventricular AP 
Model 
The same protocol used to analyze APD90, was also used to investigate how the model 
variables drive the emergence of EADs. The myocyte was again paced at near resting pacing rates 
(1000 ms, 60 bpm) for 1000 cycles and the following 15 beats were recorded. For this part of the 
study, LTCCs were distributed into the 6 different subgroups represented in Figure 3.1 by varying 
the model variables f_TT, f_B2AR and f_PDE. The probability that an LTCC was corresponding to 
one of the subgroups was computed by multiplying these state variables. The procedure was 
repeated for values of f_TT and f_PDE uniformly covering the range of possible values from 0.0 to 
1.0 in increments of 0.1, and for values of the f_B2AR ranging from 0.0 to 1.0 in increments of 0.25. 
















Figure 3.2 LTCC distribution between the 6 different subgroups (A-F) for each case 
analyzed (1-6). The total number of LTCCs in the cells from each case was kept constant, but the 
channels were divided into the 6 Subgroups in the ratios displayed. In case 1, 80% of the channels 
are located inside the T-tubular membrane, while the remaining ones were distributed to the 
remaining subgroups based on their probability to be associated with PDEs and β2ARs. In case 2, 
the dominant channel population was represented by channels located in T-tubules, lacking PDE 
association, while in case 3, the majority of channels were also located in the T-tubular membrane, 
but were not associated with β2ARs.   Cases 4, 5 and 6 are similar to Cases 1, 2, and 3, but their 
dominant channel populations are located in the surface sarcolemma.  
 
3.3 Results 
3.3.1 HF Remodeling Leads to a Higher Amplitude, Longer Lasting 
LTCC current. 
The LTCC current traces from the cases outlined in Figure 3.2 are plotted in Figure 3.3 
under both basal and adrenergic stimulation conditions. The control case (Figure 3.3, case 1 - black) 
was represented by the LTCC current in the healthy myocyte with intact tubulation as well as 
localization of β2AR and PDE activity. LTCC current decay was rapid, especially in the T-tubules (τ 
1=18.7 ms, τ 2=318.3 ms), due to the strong CDI caused by the accumulation of Ca
2+ in the dyadic 
volume of the model. β2AR stimulation in the control case led to an increase in the magnitude of 
LTCC current and a faster decay rate (τ 1=18.3 ms, τ 2=257 ms), as compared to the basal conditions 
(Figure 3.3, case 1 - red). The effect of PDE on controlling cAMP levels and thus LTCCs level of 
phosphorylation was evaluated by removing PDE from the model (Figure 3.3, case 2). Although this 
change had little to no effect for the case with basal PKA phosphorylation (black), it considerably 
increased LTCC current peak when adrenergic stimulation was applied (red). This showed that PDE 




by the hydrolyzing activity of PDE on cAMP. Removing all β2ARs led to smaller currents as PKA 
did not phosphorylate any channel (Figure 3.3, case 3). In the control case, when tubulation was 
removed and LTCCs shifted to the surface membrane (Figure 3.3, case 4), Ca2+ was not able to 
accumulate in significant amounts in the proximity of the LTCCs. Thus CDI was delayed, peak 
current was elevated, and ICaL inactivation rate was lower (τ 1=29.0 ms, τ2=3392 ms).  Applying β2AR 
stimulation in this case led to an even larger in magnitude and slower current (Figure 3.3, case 4 – 
red), and removing PDE further exacerbated this effect (Figure 3.3, case 5).  Removing T-tubules 
when β2ARs were absent (Figure 3.3, case 6) led to a slower decaying current, of similar magnitude 
to that in fully tubulated cells. Overall, subcellular changes associated with the HF phenotype, such 
as de-tubulation, LTCC redistribution to the surface membrane, and loss of β2AR and PDE 

















Figure 3.3 The effect of microstructure remodeling on LTCC current. Total LTCC current was 
plotted over time from cells corresponding to cases 1-6 described in methods, under both basal 
(black) and sympathetic stimulation (red) conditions. The decay time constants for the current 
through the channels in the T-tubules and the ones in the bulk of the sarcolemma were displayed as 
τ 1 and τ 2. 
 
 
3.3.2 HF Remodeling Leads to Altered SR Ca Release and Ca 
transient 
For each of the cases described above, the Ca2+ flux from the SR into the cytoplasm through 
RyRs is plotted in Figure 3.4 and the Ca2+ concentration inside the cytoplasm in Figure 3.5. When 
adrenergic stimulation is applied, the β2AR /G-protein/AC/cAMP/PKA signaling cascade is 
triggered, which leads to the phosphorylation of RyRs along with LTCCs. Thus, not only do RyRs 
experience a higher Ca2+ concentration in the dyadic space due to the phosphorylation of LTCCs, 
but their activity is also enhanced by direct PKA phosphorylation, leading to a higher Ca2+ flux from 
the SR into the cytoplasm (Figure 3.4). However, due to the higher Ca2+ concentration inside the 
dyadic space, RyRs deactivate faster under adrenergic conditions, and the Ca2+ concentration inside 
the cytoplasm does not differ greatly between baseline and adrenergic stimulation conditions in 
intact myocytes (Figure 3.5). The β2AR enhancing effect on Ca
2+ release appears stronger when the 
microdomain is degraded. By removing T-tubules, we disrupt the association between LTCCs and 
RyRs within the dyadic space. Removing T-tubules and relocating LTCCs from the dyadic space to 




weaker release of Ca2+ from the SR into the cytoplasm. While completely removing β2AR molecules 
in the intact HF myocyte model leads to a lower amount of Ca2+ being released via RyRs in, it has 
the opposite effect in de-tubulated cells (Figure 3.4). This is explained by the fact that LTCCs in the 
surface membrane experience CaMKII phosphorylation, while those in the T-tubular membrane do 
not [15]. Overall, the Ca2+ concentration inside intact myocytes is higher than that in de-tubulated 
cells due to higher LTCC current through T-tubular channels, and an increase in the flux of Ca from 
the SR into the cytoplasm.  
 
Figure 3.4 The effect of microstructure remodeling on SR Ca2+ release. 
The Ca2+ flux from the SR into the cytoplasm via RyRs was plotted over time from cells 






Figure 3.5. The effect of microstructure remodeling on INaCa current. 
The INaCa current was plotted over time from cells corresponding to cases 1-6, under both basal (left) 
and sympathetic stimulation (right) conditions. 
 
3.3.3 Changes in ICaL and RyR Function Impact the NCX Current.  
The NCX current traces from the cases outlined in Figure 3.2 are plotted in Figure 3.6 under 
both basal and adrenergic stimulation conditions. Similar to the re-distributed LTCCs, NCX 
molecules which shifted to the surface membrane experience the Ca2+ concentration from the sub-
sarcolemmal volume. Under baseline conditions, microdomain loss lead to a small decrease in INaCa 
corresponding to a lower SR Ca release and an overall lower Ca2+ transient. However, similar to ICaL, 
under adrenergic stimulation INaCa displayed an increase in amplitude when the myocyte underwent 
de-tubulation, but not a slowdown in decay rate. These results can be explained based on the 
observations we made before on RyR and LTCC function. NCX is an antiport driven by the 
concentration gradients of Ca2+ and Sodium. A high amplitude ICaL within a de-tubulated cell leads to 




between the inside and outside of the cell. Thus, we observe a high amplitude INaCa under adrenergic 


















Figure 3.6 The effect of microstructure remodeling on Ca2+ transient. 
The Ca2+ concentration inside the cytoplasm was plotted over time from cells corresponding to 






3.3.4 Abnormal LTCC Current Affects APD90 
We then analyzed the effect of varying the parameters encoding for T-tubule integrity, β2AR 
and PDE on AP shape and duration. The membrane potential corresponding to the six cases 
described above was plotted in Figure 3.7. For the control case under no adrenergic stimulation, an 
APD90 of 281 ms was recorded. Adding β2AR stimulation lead to an increase and slower decay rate 
in the LTCC current, which caused a slight prolongation of APD90 to 308 ms (Figure 3.7, case 1). 
Removing PDEs from the model and applying β2AR stimulation caused the emergence of single 
EADs in intact myocytes (Figure 3.7, case 2). Removing all β2ARs from the model, on the other 
hand, had the opposite effect, preventing EADs and causing APD90 to shorten (Figure 3.7, case 3). 
When tubulation was removed from the control case, and no adrenergic stimulation applied, the 
observed increase in LTCC current led to a corresponding 44 ms APD90 prolongation.  
The effect of β2-stimulaton was significantly stronger in the absence of T-tubules resulting in 
an APD90 of 517 / 668 ms and the development of multiple EADs (Figure 3.7, case 4). However, in 
de-tubulated myocytes, applying adrenergic stimulation while lacking PDE led to an oscillatory state 
in which the cells did not repolarize before the next stimulus was applied (Figure 3.7, case 5). 























Figure 3.7 The effect of microstructure remodeling on membrane voltage and APs. The 
membrane potential of cells from cases 1-6 is plotted over time under both basal (black) and 
sympathetic stimulation (red) conditions. EADs emerged only under sympathetic stimulation in the 
cells where most LTCCs were either located in the T-tubules and lacking PDEs (case 2), or they 
were in the surface membrane and experienced the effect of both β2ARs and PDEs (case 4). When 
most LTCCs were located in the bulk of the sarcolemma and were not associated with PDEs (case 
5), the cells were not able to repolarize and remained in an oscillatory state until the next stimulus 
was applied. 
3.3.5 Effects of de-tubulation and β2AR loss on APD90 
Lastly, we analyzed how gradual changes in the amount of de-tubulation as well as β2AR and 
PDE signaling localization affect APD90 and EAD development. The heatmaps in Figure 3.8 were 
plotted in order to quantify how each of these variables impacts APD90 and EAD formation. The 
results demonstrate that EADs occurred only under adrenergic stimulation. Moreover, the loss of 
PDE control of cAMP in the dyadic space also contributed to the emergence of EADs.  
No EADs formed when only 25% of the β2ARs were present. When 50% of the β2ARs were 
present EADs emerged either in fully de-tubulated cells, or in cells that lacked more than 20% of 
their PDE. In all the other cells, APDs appeared to increase proportionally to PDE and tubulation 
loss but no arrhythmogenic triggers were observed. The same trend was detected when the amount 




emergence, while the presence of intact tubulation and PDE had a protective effect. When all β2ARs 
were present and functional, the model generated membrane potential oscillations for most cells that 
were lacking more than 60% of their initial T-tubules. EADs were obtained in almost all other cases, 
except the one in which tubulation was intact and at least 90% of PDEs were present. Thus, the 
presence of PDE molecules had a protecting effect, opposing APD90 prolongation and in some 
cases inhibiting EAD development. 
 
Figure 3.8 The effect of microstructure remodeling on APD90 and EAD emergence. 
Heatmaps of the average APD90 under sympathetic stimulation for 4 fixed values of  the f_B2AR 
parameter. The cells range from intact (f_TT=1.0) to fully de-tubulated (f_TT = 0.0), and PDEs 
range from present and fully functional (f_PDE = 1.0) to completely absent (f_PDE = 0.0). EAD 






3.4.1 Findings and Significance 
Because HF electrophysiological remodeling is such a complex phenomenon, for the 
purpose of this computational study we used simulations to model and integrate only the structural 
changes described above. There are multiple other aspects described in Limitations that could be 
introduced in subsequent studies. Thus, the goal of this project was to elucidate the mechanisms by 
which subcellular changes in cardiac myocytes lead, via altered LTCC function, and under adrenergic 
stimulation, to the generation of cellular-level triggers of arrhythmia in human HF. To accomplish 
this goal, we developed a new ventricular myocyte computational approach that integrated various 
known characteristics of HF and allowed us to vary their severity. The model included the effects of 
microdomain remodeling on LTCC as in study by Sanchez and colleagues [15], as well as novel 
developments incorporating β2AR stimulation, and arrhythmogenic remodeling of β2 adrenergic 
signaling, as well as impaired control of cAMP levels due to altered PDE localization.  We found 
that redistribution of the LTCCs combined with an enhanced phosphorylation of the channel due to 
abnormally high cAMP levels caused increases in LTCC current magnitude and duration. This 
resulted in AP prolongation and the development of single EADs, multiple EADs, or oscillations, 
depending on the amount of remodeling present. 
 
3.4.2 Transverse T-tubules Loss in HF 
The T-tubule system plays a vital role in normal ventricular cell function. Its structure and 




triggering of Ca2+ release from the sarcoplasmic reticulum. The increase in Ca2+ levels throughout 
the cytoplasm leads to the coordinated contraction of all contractile units inside a cell [35]. Scanning 
ion conductance microscopy (SICM) and fluorescence staining experiments have shown that 
ventricular myocytes obtained from HF patients are characterized by a decrease in T-tubule density 
[12], [35]. This change in surface topography has been shown to take place gradually as the cardiac 
muscle transitions from hypertrophy to HF and to have a negative impact of excitation-contraction 
coupling [35]. Song and colleagues proposed that this deleterious effect is due to the reorganization 
of subcellular microdomains, which force RyRs to decouple from their partner LTCC and become 
orphaned. Thus Ca2+ ions flowing through the LTCCs fail to bind to RyRs and do not cause further 
Ca2+ release from the SR [36].  Other studies have shown that in HF, the loss of T-tubule 
microdomains is usually complemented by a spatial redistribution of LTCCs from the T-tubule 
membrane to the bulk of the sarcolemma, where they experience a different signaling environment 
[15]. Finally, work by Kawai and colleagues [37] and Bryant and colleagues [34] showed that 
complete myocyte de-tubulation is associated with  reduction in ICaL and shortening of APD. Taken 
together, the findings of these previous experimental studies suggest that altered LTCC function is a 
likely candidate for the mechanism linking T-tubule microdomain loss to the emergence of 
arrhythmogenic triggers in ventricular HF myocytes.  
A novel aspect of our simulation approach lies in the fact that instead of creating a single 
model, by varying the amount of remodeling we obtained a family of models which allowed us to get 
an accurate depiction of the implications of T-tubule and cAMP compartmentalization loss in HF. 
By using this approach, we were able to analyze the effects of T-tubular loss alone, as well as in 




resembled the progression of the disease. Because our study showed an increase in ICaL and APD 
due to de-tubulation, it appears that our results are at odds with the results by Kawai et al., [37] and 
Bryant et al. [14]. However, that is not the case. The difference in our results comes mainly from the 
way we define de-tubulation and the exact distribution of channels between the T-tubular and the 
bulk of the sarcolemma. In our study, we view T-tubular microdomain disruption as a gradual 
process which slowly advances as HF progresses, similar to the changes that the myocytes from the 
above-mentioned studies undergo after coronary artery ligation (CAL). We are not trying to 
reproduce the data from a specific phase of the disease, as that would be impossible without 
introducing all the aspects of HF electrophysiological remodeling, but rather analyze the specific 
changes caused by gradual de-tubulation and cAMP re-distribution. If we compare one of our 
myocyte models constructed using the same ratio of channels in the T-tubular membrane vs. the 
bulk of the sarcolemma as in the CAL myocytes from the Bryant and colleagues, with what would 
be the equivalent of a healthy human myocyte in the study by Sanchez and colleagues [15], we get 
similar whole cell ICaL current density (data not shown). However, because in their study de-
tubulation is defined as a fast, chemical process which completely removes all T-tubular 
microdomain, and in our model de-tubulation is a slow process which allows the channels to 
relocate to the surface membrane, our results are different when we analyze de-tubulation. We could 
partially replicate their results if we completely eliminated the T-tubular component of ICaL.  
Furthermore, even though our results show an increase in ICaL density due to HF when there 
are no experimental studies in humans showing that, we have to keep in mind that ICaL peak and 
density seem to vary in HF from study to study [10], and in-silico studies don’t always match the 




common change in ICaL morphology caused by HF which is a slowing of the decay of the whole-cell 
current. Thus, our findings are consistent with the findings described above. They reproduce the 
change in ICaL shape, add new insight about different stages of the disease, and highlight the 
existence of a threshold of T-tubule integrity that can predict the development of cellular level 
triggers of arrhythmia, as seen in Figure 3.8. 
 
 
3.4.3 The role of β2AR and PDE signaling localization loss in EAD 
development 
Another hallmark of HF is βAR desensitization. Wright and colleagues showed, by 
combining a nanoscale SICM with a fluorescence resonance energy transfer (FRET) approach, that 
in healthy ventricular myocytes β2AR-induced cAMP signals were highly localized within the T-
tubular domain [19]. Heijman and colleagues used a computational model to describe in great detail 
the quantitative contribution of various molecules, including LTCCs, and the effects of the above 
mentioned signaling localization in adrenergic stimulation [22]. In HF myocytes, sympathetic 
stimulation of β2AR appears to result in diffused, far reaching cAMP signals, which resembled those 
obtained via β1AR stimulation. This suggests that similar to LTCCs, β2ARs also change location 
from the T-tubular membrane to the surface membrane when tubulation is lost [18]. In addition, 
Lang and colleagues demonstrated that during end-stage HF, β2AR stimulation leads to 
heterogeneities in APD and arrhythmogenic activity [39]. In our study, we were able to control the 
degree of both PDE and β2AR loss of function and redistribution and to analyze how it influences 




Completely blocking β2AR function in the model did not lead to abnormal LTCC current, nor to 
EAD occurrence. This is consistent with the fact that ligand binding failed to trigger a signaling 
cascade, and LTCCs were never phosphorylated (βAR desensitization). It also explains why 
adrenergic blockers work well as antiarrhythmic agents. When the β2AR molecules were allowed to 
maintain partial functionality, but lost their localization, significant increases in LTCC current 
magnitude and APD90 as well as EAD development were observed. Moreover, when all β2AR 
molecules were present, instead of EADs, the cells displayed an oscillatory behavior in which the 
membrane potential did not return to its baseline value. This is a biological phenomenon also 
recorded in isoprenaline perfused rabbit ventricular cardiomyocytes affected by long QT syndrome 
and thought to lead to sudden cardiac death [40]. These changes were opposed by the presence of 
PDE, which appears to have a protective, anti-arrhythmogenic effect. The new mechanistic insights 
presented here show that the binding of the ligand to functional, redistributed β2ARs causes a cAMP 
signal propagation and amplification throughout the cell, which leads to the phosphorylation of 
multiple LTCCs across the cell membrane. Phosphorylated LTCCs have a higher open probability, 




Altered LTCC current is a major factor in the process linking microstructural remodeling to 
the increased risk of cellular arrhythmia triggers development in HF patients. Our results show that 
the disruption of subcellular microdomains and the redistribution of LTCCs, PDEs and β2ARs 




are thus prolonged and upon sympathetic stimulation, EADs may arise. These findings provide 
important insight into the mechanism underlying the development of cellular level triggers of 
arrhythmia in human HF and suggest β2ARs and PDEs as possible targets for future therapies and 





Our study has several limitations. HF remodeling is a very complex process with many 
unknowns. Our model thus had various assumptions. First, in the lack of experimental evidence 
otherwise, we assumed that the LTCCs remaining in the T-tubular membrane in HF are fully 
functional; even super-resolution scanning patch clamp studies such as the one presented by 
Sanchez et. al [15] cannot measure LTCC activity deep inside the T-tubule system. Secondly, in 
order to be able to draw mechanistic insight, we limited the degrees of freedom of our model by 
keeping both the number of LTCCs as well as their conductance constant. This may be at odds with 
observations by Bryant et. al which suggest that in heart failure, myocytes show a decrease in the 
number of LTCCs and an increase in their activity [34]. Also, our model focused exclusively on the 
activity of LTCC channels in HF, and did not include changes in other currents such as INa,L, IKs and 
IKr which are also affected by HF remodeling. Due to limited data on PKA-mediated 
phosphorylation of LTCCs in HF, by using only the electrophysiological and not the signaling 
module of the model Heijman model [22], we had to make approximations regarding the fraction of 




study focuses exclusively on the effect of microdomain loss on β2AR, based on previous studies 
showing that HF leads to the re-distribution of these receptors which in turn affects the activity of 
LTCCs [18], although β1AR stimulation is the major receptor mediating the effects of sympathetic 
stimulation of the heart. This could be explored in greater depth in future work. CaMKII-dependent 
phosphorylation of different channels was also included in the model, but as our study focused 
solely on the effect of sympathetic stimulation and PKA-dependent phosphorylation of LTCCs, 
CaMKII remodeling was not implemented. Since PDE3 acts as a negative feedback-loop for cAMP 
level control, the model assumed that PDE3-mediated cAMP degradation is a process activated by 
PKA and thus PDE should only be active under sympathetic stimulation when PKA levels are 
increased. Also, only the activity of PDE3 was modeled and PDE signaling localization loss was 
modeled to be directly proportional to T-tubular loss. In further studies, the model will account for 
different isoforms of PDEs as decribed by Zhao et al. [30]. Lastly, the present study focused on 
single cell behavior; thus, it is possible that the results can be modulated by the effect of cell 














Chapter 4: Altered L-type Calcium Channels Function 
Differentiates between Ischemic and Dilated 
Cardiomyopathies. 
 
This work is part of a study submitted for publication.  
 
4.1 Introduction 
As structural heart diseases such as myocardial hypertrophy progress from an early form 
towards advanced HF, patients acquire a higher risk of developing arrhythmias and sudden cardiac 
death. Although for decades, LTCCs have been suggested as a possible contributor to an abnormal 
cardiac function in HF, not much attention has been given to their regional variation within a cell, nor 
to their functional variation across different disease etiologies. Several studies have shown that T-
tubular microdomains are lost in HF [41], while base-line whole cell ICaL stays unchanged [33], [32], 
[42]. This suggests that LTCCs in HF may be hyperphosphorylated in order to compensate for channel 
loss. In fact, studies on single channel recordings by other authors have shown an increase in LTCC 
open probability in human HF [15], which could be explained by a higher phosphorylation of the 




been observed on channels located in the T-tubular membrane, in dilated cardiomyopathies (DCM) 
the channels in the bulk of the sarcolemma show a higher open probability. This microdomain- 
specific abnormality in LTCC behavior was found to depend on whether the channels were 
hyperphosphorylated by PKA or by CaMKII.  
The goal of this study was to explore the mechanisms by which HF-induced changes in 
phosphorylation patterns due to PKA in the ICM case and CAMKII in the DCM case combined with 
an altered LTCC distribution to cause an abnormal LTCC current which promotes the development 
of EADs in human ventricular myocytes. To this end, we employed three different ionic models to 
analyze the LTCC channel behavior as well as AP generation in silico. Our results show valuable 
insight into the processes that favor the development of cellular arrhythmogenic triggers in HF 
patients as well as the effect of these triggers at whole-organ level. 
 
4.2 Methods 
4.2.1 Modeling Methodology 
The O’Hara-Rudy ionic model[43] was used to represent the electrophysiology of healthy 
human ventricular cardiomyocytes. Additionally, we developed both endocardial and epicardial 
models for three different cases (control, DCM and ICM), in order to perform single-cell simulations. 
Whole-cell LTCC current behavior, APs and the possible emergence of cellular-level triggers of 
arrhythmias were studied. The ionic models were then used in an MRI-derived, anatomically realistic, 
healthy human ventricular model, to evaluate if the EADs observed in single-cell simulations would 







4.2.2 Single Cell Modeling Methodology 
As previously mentioned, the O’Hara-Rudy ionic model[43] was used to model action 
potentials in healthy human ventricular cardiomyocytes. We introduced a number of changes in the 
formulation of the human LTCC current, in order to represent the subcellular remodeling observed 
in different etiologies of cardiomyopathy. Myocytes from dilated human hearts were modeled by 
incorporating the changes in the ionic model described in previous work[15]. To model cells from 
ischemic human hearts, we introduced modifications based on the experimental data from the 
Gorelick lab. Specifically, we introduced a parameter defining T-tubular integrity and set its value to 
0.65. Next, we allowed a fraction of 0.45 LTCCs within a cell to maintain their position within the T-
tubular membrane, while the remaining 0.55 fraction of channels were relocated to the bulk of the 
sarcolemma. These values were computed using the data describing T-tubular density and regularity 
and channel occurrence and are explained in more detail in the following sections. As observed 
experimentally, there was an increase in Po of LTCCs on the non T-tubular sarcolemma for the DCM 
etiology, and in the T-tubule membrane in the ICM case. While in DCM myocytes this change occurs 
due to phosphorylation of LTCCs by CaMKII, in ICM myocytes PKA appears to be responsible for 
the enhancement of LTCC phosphorylation. Therefore, we introduced PKA into our ICM 
cardiomyocyte model and allowed it to interact with the LTCCs present in the T-tubular domain. 
Similar to the O’Hara-Rudy human ventricular model combined with the electrophysiological module 
of the Heijman beta adrenergic model[22] described previously[23], when PKA phosphorylated an 




were updated. However, while all LTCCs in the non T-tubular sarcolemma were assumed to operate 
in the CaMKII-phosphorylated mode in DCM, only a fraction of 0.7 LTCCs in the T-tubules in ICM 
were set to function in the PKA-phosphorylated mode, in order to match the Po observed 
experimentally, as described below. 
Apart from the remodeling observed in the LTCC current, all the other ionic changes 
described in the study by Sanchez-Alonso and colleagues[15] representing DCM cardiomyopathy were 
also included in the model of the ICM etiology. Thus, within the model, the formulation of the LTCC 
current is what differentiates between the ICM and DCM cases. 
 Finally, we represented the electrophysiological differences in ionic remodeling between epi- 
and endocardial cells in each etiology using the same approach as the study by Elshrif and colleagues 
[38]. 
Using the three models described above (control, DCM and ICM), for both endocardial and 
epicardial myocytes, we performed single-cell simulations using both a voltage-clamp protocol to 
analyze the whole-cell LTCC current behavior, and a pacing protocol in order to observe differences 
in action potentials and the possible emergence of cellular-level triggers of arrhythmias such as EADs.  
 
4.2.3 Accounting for T-tubular Loss and LTCC Redistribution in 
Ischemic Cardiomyopathies 
The modified O’Hara-Rudy model was used in both the Sanchez-Alonso et al. study[15] and 
our current study to represent the control case had intact T-tubular domains. In order to model the 
loss of T-tubules observed experimentally in ischemic cardiomyopathies we introduced the parameter 





TT density in ICM
TT density in control
+  
Z groove ratio in ICM
Z groove ratio in control




Then, we introduced two new parameters encoding for the distribution of LTCCs between 
the T-tubular region and the Non T-tubular sarcolemma domains. Thus, the ratio between the 
channels located in the T-tubular domain to the channels located in the Non T-tubular sarcolemma 
was found to be 0.8 using the equation: 
# channels in TT
# channels in non T − tubular sarcolemma
=  
Percentage of recordings with LTCCs on the TT
Percentage of recordings with LTCCs on the Non T − tubular sarcolemma
 
Therefore, a fraction of approximately 0.45 of LTCCs within a cell were located on the T-
tubular membrane, while the remaining 0.55 were relocated to the Non T-tubular sarcolemma.  
As experimental evidence from human myocytes has indicated that remodeling has no effect 
on the peak of the LTCC current[43], we adjusted the whole cell LTCC current to match that of the 
control in terms of magnitude, by multiplying it with a correction factor.  
 
4.2.4 Setting the Fraction of LTCCs in ICM T-tubules to be 
Phosphorylated by PKA 
Similar to the Sanchez et. al study[15], we used a stochastic Markov formulation to model the 
single channel behavior and determine the appropriate fraction of channels which would undergo 
PKA phosphorylation in ICM T-tubules, in order to match the experimentally observed open 
probability value. We used the same 32 sates Markov model described in a previous study [15] to 




additional equivalent states were created, all characterized by different gating kinetics as described in 
the O’Hara-Rudy model combined with the Heijman model[22], [23]. By stochastically simulating the 
behavior of 1000 channels at a voltage of -6.7mV, we determined that only a fraction of 0.7 LTCC 
channels need to be phosphorylated in order to match the desired open probability. This is different 
that the DCM model in which all channels in the non T-tubular sarcolemma were phosphorylated by 
CaMKII. After computing this fraction, we reverted the Markov model to the equivalent Hodgkin-
Huxley formalism.   
 
4.2.5 Whole-heart modeling approach 
 To evaluate whether EADs observed in the cell-level simulations would develop into 
reentrant arrhythmias in a human heart, we used our ICM, DCM and control ionic models for both 
endocardial and epicardial myocytes, and implemented them in an MRI-derived, anatomically realistic, 
healthy human ventricular model. The same model was utilized in a previous study[15], in which 
transmural electrophysiological differences (epi- vs. endo-) in the ventricles were represented by 
dividing the ventricular walls into an epi- and endocardial layers and using the corresponding ionic 
model for each region based on experimental data. Transmural conductivity was implemented as a 
gradient between the epi- and endocardial surfaces based on experimental data from human left 
ventricle[44], as done in a previous study[15]. A computational mesh with  resolution of <300μm was 
generated and fiber orientation was assigned using a rule-based approach[45]. Stimuli were applied at 
the apex of the ventricles using a 2.5 mm virtual electrode. Two initial stimuli were delivered at 1s 
intervals, followed by a pause in stimulation representing two skipped heart beats, similar to our 




regular pacing at 1Hz was resumed. The simulations were performed using the CARP software 





4.3.1 Cellular Level Computational Modeling Predicts Abnormal 
LTCC behavior in both DCM and ICM etiologies 
 In single-cell voltage clamp simulations using either the endocardial or epicardial myocyte 
models described in the Methods section, stepping the membrane voltage from -96.7 mV to -6.7mV, 
as in the experimental protocol, led to an influx of Ca2+ ions into the cell similar in magnitude across 
all the three cases (control, DCM and ICM), which agrees with previous findings[32], [33], [42]. The 
rate at which these currents decayed however, varied between the three cases, with the control case 
displaying the fastest rate, and the DCM being the slowest. This suggests that LTCC current could be 
a potential cause of action potential prolongation and its destabilization in the ICM and DCM models. 
Examining the ICa,L current through the channels located exclusively in the T-tubular microdomains, 
we found that its values in the control and ICM model myocytes were nearly identical in terms of 
magnitude, while the magnitude of the ICa,L current in DCM was significantly lower. Thus, although 
there are fewer channels in the TT domain in both cardiomyopathy etiologies, in ICM myocytes, the 
TT operating under PKA-phosphorylation mode compensate for the loss of channels due to LTCC 




through the LTCC channels. A surprising result of these simulations was, however, that all currents 
in the T-tubular membrane for the three myocyte cases showed very similar decay rates. While this 
was expected for the control and DCM cells, in which the channels are not phosphorylated, it was an 
unexpected result from the ICM myocyte model, in which channels in the T-tubular domains 
experience the effect of PKA phosphorylation and thus have a higher Po. This result can be explained 
by the fact that LTCCs experience both voltage and Ca2+ dependent inactivation, and that at 
hyperpolarized potentials such as -6.7 mV Ca2+ dependent inactivation is stronger than voltage 
dependent inactivation. Within the dyadic space, the high Ca2+ concentration rapidly inactivates the 
channels in all pathology cases and keeps a close control of channel opening, thus leading to currents 
with very similar decay rates. On the other hand, in the non T-tubular sarcolemma microdomain the 
Ca2+ dependent inactivation is lower; since Ca2+ does not accumulate as much, voltage dependent 
inactivation dominates, and thus all channels there display a slower decaying current than in T-tubules. 
This slower decay of ICa,L is exacerbated in the DCM case by the phosphorylating effect of CaMKII 
on non T-tubular sarcolemma LTCCs leading to a higher-amplitude and a slower-decaying current.  
 
 
Figure 4.1 Overview of  whole L-type calcium current model under voltage-clamp protocol. 
The LTCC current from the control (black), DCM (blue) and ICM (red) cases was plotted over time 
after the voltage was stepped from -96.7 to -6.7 mV. The currents were then normalized and plotted 




LTCC current (first row), the LTCC current through the channels in the TT (second row) and the one 




4.3.2 Single Cell Simulations Also Predict the Emergence of Cellular-
Level Triggers of Arrhythmia in both DCM and ICM Etiologies  
When myocyte models were paced at 0.25Hz, simulation results demonstrated that the 
changes in LTCC kinetics described above lead to the emergence of early afterdepolarization (EADs) 
exclusively in the endocardial myocytes of ICM and DCM patients. Blocking the phosphorylating 
effects of PKA and CaMKII on LTCCs in the pathological cases led to the disappearance of the EADs 
under an identical protocol (Figure 4.2), which indicates that the two molecules play key roles in the 
development of cellular-level triggers of arrhythmia in cardiomyopathies.  
Even though EADs can act as triggers of ectopic beats, their formation does not often result 
in the emergence of reentrant arrhythmias in the whole heart. Thus, we conducted organ-level 
simulation with the whole-heart ventricular models described in Methods to examine the conditions 





Figure 4.2 Comparison of  membrane voltage and L-type Calcium current traces. The 
membrane voltage and corresponding L-type Calcium current traces were plotted over time when the 
model myocytes were paced at 0.25Hz. Models of  myocytes from control, ischemic and dilated hearts 
are represented. For the ICM case, EADs were obtained when the LTCCs in the T-tubuless were 
phosphorylated by PKA (top row, left), but not when PKA activity was blocked (top row, right). 
Similarly, arrhythmogenic triggers developed in the DCM case when LTCCs from the non T-tubular 
sarcolemma were phosphorylated by CaMKII (bottom row, left), and not when CaMKII activity was 
blocked (bottom row, right). Changes in L-type Calcium current morphology, but not peak magnitude 
was observed when phosphorylation was blocked. However, changes in the amplitude of  the current 
through the channels in both T-tubular membrane and non T-tubular sarcolemma were observed 









4.3.3 Organ-scale Simulations Predict the Development of 
Arrhythmias in the DCM, but not in the ICM Cardiomyopathy 
 As in the single-cell simulations, arrhythmogenic activity in the whole-heart (see Methods for 
description) arose from the endocardial layer. The formation of arrhythmogenic triggers only in the 
ICM ventricles and of both arrhythmogenic triggers and reentrant arrhythmia in the DCM ventricles 
is illustrated in Figure 4.3. No arrhythmic events were observed in the control case. Action potential 
duration of the first two beats following stimulation was found to be significantly increased (compared 
to control) in both pathological cases. Skipping the subsequent two beats to facilitate EAD emergence, 
as done in previous work at cellular level[15], had no effect in the control ventricles but led to reentrant 
arrhythmia in the DCM heart model. In contrast, when we skipped two beats in the ICM ventricular 
model, we observed emergence of EADs only in a small island of tissue, and it did not develop into a 
reentrant arrhythmia.  
Overall, our simulations showed how the loss of TT and the subsequent redistribution of LTCCs alters 
cellular action potential. EADs have been widely described in the literature [48], and our simulations 
demonstrating emergence of EADs in ICM and DCM cells are consistent with these studies (Figure 4.2).   
In our DCM model, CaMKII phosphorylated LTCCs in the non T-tubular sarcolemma, resulting in an altered 
non T-tubular sarcolemma ICaL compared to control, with a higher magnitude and a slower decay (Figure 
4.1). These changes were the main cause for EAD emergence. In ICM, PKA phosphorylated LTCCs mostly 
in TT, however, TT ICaL had the magnitude and kinetics of control (Figure 4.1), as the loss of LTCCs in this 
microdomain was compensated by the increase in Po through PKA phosphorylation of the channels 




exchanger, sarcolemmal Ca2+-ATPase and the SR Ca2+ uptake pump are more efficient on TT than on the 
non T-tubular sarcolemma. This reveals new insights into the mechanism of HF, indicating how the 
location of LTCCs could be more important than their phosphorylation state.  
Whole heart simulations demonstrated that LTCC alterations in DCM have worse consequences at the 
organ level (reentrant arrhythmias) than LTCC alterations in ICM (Figure 4.3). This points to the subcellular 
location as being a key player in the process of LTCCs becoming the trigger of arrhythmogenic events. 
When LTCCs are located in TT, the machinery of the cell in this microdomain can precisely control calcium 
influx and even compensate for channel loss with an increase in Po. However, when LTCCs are located in 
the non T-tubular sarcolemma, balance is easily disrupted, and an increase in channel number there leads 
to EADs (as shown by ICM simulations). If this is accompanied by an increase in Po (DCM simulations), 
electrophysiological disturbances will progress to reentrant arrhythmias. 
 our simulations demonstrated that subtle differences in microdomain remodeling between 
ICM and DCM cardiomyopathies lead to very different electrophysiological outcomes at the whole-












Figure 4.3 Graphical representation of  the whole heart simulations. (A) The voltage maps from 
4 different points in time were plotted for the three cases (Control, ICM, DCM). A short 
depolarization between two consecutive stimuli was recorded in the ICM heart, while a reentrant 
arrhythmia was obtained in the DCM organ. (B) The membrane potential was recorded from three 
different virtual electrodes in the ventricles and displayed. In the ICM case, an island of  tissue 
displayed a synchronous single EAD following the stimulus after the skipped 2 beats. In the DCM 






Because abnormal Ca2+ signaling is a known contributor to the pathology of human HF, its signaling 
pathways are typically targeted in current therapies for HF. In this study, we combined experimental 
data from the Gorelick lab with our computational models in order to gain new insights into the 
emergence of arrhythmogenic triggers and re-entrant arrhythmia in different human HF etiologies. 
Specifically, we analyzed the two different pathways observed in the progression of ICM and DCM: a 
pathological activation of CaMKII in DCM cardiomyopathies and of PKA in ICM cardiomyopathies. 
Our research showed how sub-cellular microstructure changes in HF can lead to electrical dysfunction 
at organ level, and how the phosphorylation state of LTCCs in different microdomains can trigger 
arrhythmogenic events in the whole heart.  
 
4.4.1 The Etiology of the Disease Determines Microdomain-
dependent Phosphorylation of LTCCs either by PKA or CaMKII 
The two main kinases known to modulate LTCC activity in human cardiomyocytes are PKA and 
CaMKII [49]. The behavior of LTCCs is regulated by the kinases’ interactions with the C-terminal of 
the α subunit of the channel [50], [51]. The progression of HF is usually associated with various 
changes in PKA and CaMKII activity, including oxidation, altered expression and post-translational 
changes. A previous study by Sanchez-Alonso and colleagues [15] showed that an increase in the 
activity of CaMKII is responsible for the changes observed in human DCM myocytes, including the 
high Po of LTCCs relocated to the bulk of the sarcolemma. Since CaMKII activity does not appear to 
be enhanced in ICM cardiomyocytes, the culprit behind the increase in Po of LTCCs located in the T-
tubular part of the sarcolemma is likely to be PKA. This hypothesis is supported in a study by Han 




activity and a subsequent increase in LTCC phosphorylation. When we incorporated these separate 
pathways in our computational models, we obtained similar results in cellular-level simulations of 
DCM and ICM cardiomyocytes, and different behavior at organ scale.    
                                                                                                                                                                                                         
4.4.2 The Outcome of the Sub-cellular LTCC Distribution on the 
Whole Heart is Revealed by Simulations  
Our simulations showed how the loss of T-tubules and the subsequent redistribution of 
LTCCs alters cellular action potential. EADs have been widely described in the literature[48], and our 
simulations demonstrating emergence of EADs in ICM and DCM cells are consistent with these 
studies (Figure 4.2).   
In our DCM model, CaMKII phosphorylated LTCCs in the non T-tubular sarcolemma, 
resulting in an altered non T-tubular sarcolemma ICaL compared to control, with a higher magnitude 
and a slower decay (Figure 4.1). These changes were the main cause for EAD emergence. In ICM, 
PKA phosphorylated LTCCs mostly in T-tubules, however, T-tubular ICaL had the magnitude and 
kinetics of control (Figure 4.1), as the loss of LTCCs in this microdomain was compensated by the 
increase in Po through PKA phosphorylation of the channels remaining in TT. This suggest that the 
Ca2+ handling proteins associated with the T-tubules such as Na+-Ca2+ exchanger, sarcolemmal Ca2+-
ATPase and the SR Ca2+ uptake pump[53] are more efficient on the T-tubular membrane than on the 
non T-tubular sarcolemma. This reveals new insights into the mechanism of HF, indicating how the 
location of LTCCs could be more important than their phosphorylation state.  
Whole heart simulations demonstrated that LTCC alterations in DCM have worse 




This points to the subcellular location as being a key player in the process of LTCCs becoming the 
trigger of arrhythmogenic events. When LTCCs are located in TT, the machinery of the cell in this 
microdomain can precisely control Ca2+ influx and even compensate for channel loss with an increase 
in Po. However, when LTCCs are located in the non T-tubular sarcolemma, balance is easily disrupted, 
and an increase in channel number there leads to EADs (as shown by ICM simulations). If this is 
accompanied by an increase in Po (DCM simulations), electrophysiological disturbances will progress 
to reentrant arrhythmias. 
 
4.4.3 Clinical Implications 
 
Due to the differences observed in the progression of different etiologies of HF, the prognosis and 
survival odds of patients suffering from HF may benefit from an early diagnosis of the etiology of 
the disease. We have shown that different microdomain changes at cellular level result in different 
pathologies at organ scale. Physicians may take advantage of this result and make informed choices 
























The overarching goal of this thesis’ work was to explore a novel set of mechanisms by which sub-
cellular microdomain remodeling leads to an increased risk of lethal arrhythmias in human HF 
patients. Specifically, using biophysically detailed computer models of human cardiomyocytes, we 
have shown that altered LTCC function is a possible cause of EAD emergence at cellular level and is 
mechanistically linked to increased arrhythmia risk in at least one HF etiology.  
In Chapter 3, we have presented a comprehensive study into the effects of T-tubular microdomain 
loss in HF on LTCC behavior. We have demonstrated that the subpopulations of LTCCs which are 
relocated from the t-tubular membrane to the bulk of the sarcolemma are forced to operate in a 
non-native signaling domain which causes them to lose vital function control. The consequence of 
this change was an increase in ICaL magnitude and duration which in turn, caused AP prolongation 
and in some cases EAD development.  
In Chapter 4 we went one step further, and evaluated the effects of remodeling in two different 
cardiomyopathy etiologies, from sub-cellular to organ level. We showed that while at cellular level, 
altered LTCC function caused by an increased PKA activity in ICM and an increased CAMKII 
activity in DCM lead to similar outcomes in terms of AP prolongation and EAD formation, at organ 
level, the same changes have different results, only causing reentrant arrhythmias in the DCM 
ventricles.  
These discoveries have several important implications. First, these simulations may be useful in 




microdomains at the single cell level. Secondly, our work may be useful in informing choice of anti-
arrhythmic therapies and strategies specific to patient’s pathophysiology and type of underlying 
arrhythmic substrate. Specifically, our results highlight the importance of phosphorylated LTCC in 
the development of arrhythmias, suggesting that treatments targeting phosphorylated LTCCs as well 
as B2ARs and PDEs could be the key to HF prognosis improvement.  Lastly, our study proves once 
more the usefulness of detailed computational models in providing valuable insights into clinically 
relevant mechanisms of arrhythmogenesis. The scope of our studies, spanning multiple levels from 
molecular to whole-organ, allowed us to gain knowledge of phenomena which would be difficult, if 
not impossible, to observe in experimental settings. However, empirical data is essential in 
developing accurate computational models. Thus, as more data from experiments becomes available, 
it should be included in our present state-of-the-art models in order to further our understanding 
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T-tubule transverse tubule 
LTCC  L-type calcium channels 
Po   open probability 
PKA protein kinase A 
CAMKII  calcium-calmodulin kinase II 
β2AR  β2 adrenergic receptor 
AC  adenylyl cyclase 
cAMP  cyclic adenosine monophosphate 
AP  action potential 
EAD  early afterdepolarization 
DAD  delayed afterdepolarization 
SA node sinoatrial node 
AV node atrioventricular node 




RyR  ryanodine receptor 
NCX  Na+/Ca2+ exchanger 
CICR  Ca2+ - induced Ca2+ release 
NaK  Na+/K+ pump 
ICM  ischemic cardiomyopathy 
DCM  dilated cardiomyopathy 
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2+ current 
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+ current 
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+ current 
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+ / K+ pump current 
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+ current 
INa  fast Na
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